Almond Ldl Cholesterol Randomized Trial: What the Evidence Says

Quick Answer

Almond Ldl Cholesterol Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• This persistent inflammatory response is a key biological mechanism linking obesity to increased risk of insulin resistance, type 2 diabetes, and cardiovascular complications. [Adepoju Ayodeji (2026); evidence level 2]
• Large epidemiological studies, including the Nurses' Health Study and the ATTICA study, report that higher adherence to a MED-style dietary pattern is associated with lower concentrations of pro-inflammatory cytokines and immune cell counts. [Adepoju Ayodeji (2026); evidence level 2]
• Ginkgo biloba, Zingiber officinalis, Rosmarinus officinalis, Salvia officinalis, Crocus sativus, Emblica officinalis, Coriandrom sativum Curcuma longa in-vitro in-vivo In the last few years, there has been increased use of herbal medications for different disorders in all countries (Menghani et al. [Mohajeri Mohsen (2026); evidence level 2]
• Table 2 According to, the MMSE score was significantly improved in the almond group (p=0.001), but no significant change was observed in the control group (p=0.739). [Mohajeri Mohsen (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For almond ldl cholesterol randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Adepoju Ayodeji (2026). Almond Consumption Improves Inflammatory Profiles Independent of Weight Change: A 6-Week Randomized Controlled Trial in Adults with Obesity. DOI: 10.3390/nu18050875. PMCID: PMC12986923. PMID: 41830044. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12986923/
• Mohajeri Mohsen (2026). Almond for mild to moderate Alzheimer’s disease: A randomized clinical trial. DOI: 10.22038/ajp.2025.26297. PMCID: PMC13092157. PMID: 42011351. License: https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/ This work is licensed.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13092157/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.